Financial reports
ARS
2023 FY
Annual report to shareholders
23 Apr 24
10-K
2023 FY
Annual report
19 Mar 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
10-Q
2023 Q1
Quarterly report
10 May 23
ARS
2022 FY
Annual report to shareholders
1 May 23
10-K
2022 FY
Annual report
22 Mar 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
13 May 22
Current reports
8-K
Tempest Reports Year End 2023 Financial Results and Provides Business Update
19 Mar 24
8-K
Tempest Reports Third Quarter 2023 Financial Results and Provides Business Update
8 Nov 23
8-K
Other Events
30 Oct 23
8-K
Entry into a Material Definitive Agreement
11 Oct 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8 Sep 23
8-K
Departure of Directors or Certain Officers
7 Sep 23
8-K
Tempest Reports Second Quarter 2023 Financial Results and Provides Business Update
10 Aug 23
8-K
Departure of Directors or Certain Officers
16 Jun 23
8-K
Tempest Reports First Quarter 2023 Financial Results and Provides Business Update
10 May 23
8-K
Tempest Announces Positive Early Results from Global Randomized Phase 1b/2 Combination Study of TPST-1120 in First-Line Hepatocellular Carcinoma
28 Apr 23
Registration and prospectus
S-8
Registration of securities for employees
19 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Nov 23
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Nov 23
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Nov 23
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Nov 23
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Nov 23
S-8
Registration of securities for employees
17 Nov 23
424B5
Prospectus supplement for primary offering
12 Oct 23
8-A12B
Registration of securities on exchange
11 Oct 23
S-8
Registration of securities for employees
21 Jun 22
Proxies
DEFA14A
Additional proxy soliciting materials
23 Apr 24
DEF 14A
Definitive proxy
23 Apr 24
DEFA14A
Additional proxy soliciting materials
1 May 23
DEF 14A
Definitive proxy
1 May 23
DEFA14A
Additional proxy soliciting materials
26 May 22
DEFA14A
Additional proxy soliciting materials
9 May 22
DEFA14A
Additional proxy soliciting materials
9 May 22
DEFA14A
Additional proxy soliciting materials
2 May 22
DEF 14A
Definitive proxy
2 May 22
PRE 14A
Preliminary proxy
22 Apr 22
Other
EFFECT
Notice of effectiveness
27 May 22
CORRESP
Correspondence with SEC
24 May 22
UPLOAD
Letter from SEC
18 May 22
EFFECT
Notice of effectiveness
26 Jul 21
CORRESP
Correspondence with SEC
22 Jul 21
UPLOAD
Letter from SEC
21 Jul 21
EFFECT
Notice of effectiveness
12 May 21
CORRESP
Correspondence with SEC
7 May 21
UPLOAD
Letter from SEC
16 Apr 21
EFFECT
Notice of effectiveness
19 Apr 19
Ownership
SC 13G/A
EcoR1 Capital, LLC
14 Feb 24
SC 13G/A
Rock Springs Capital Management LP
14 Feb 24
SC 13G/A
FMR LLC
9 Feb 24
SC 13D/A
Versant Venture Capital VI, L.P.
8 Feb 24
4
Stephen R Brady
5 Jan 24
4
Samuel Whiting
5 Jan 24
4
Justin Trojanowski
5 Jan 24
4
Nicholas Maestas
5 Jan 24
SC 13D/A
Versant Venture Capital VI, L.P.
9 Nov 23
144
Notice of proposed sale of securities
2 Nov 23